BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial ...
The Division of Plastic Surgery is dedicated to delivering a broad range of reconstructive and aesthetic services, while consistently providing our patients with high-quality, compassionate care. Our ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback